Precision Fermentation Draws Investors as Alt-Proteins Lag
Alternative proteins have underperformed investor expectations due to taste, texture, and price barriers, but precision fermentation is attracting renewed

Alternative proteins have critically underperformed against expectations set a decade ago, according to a new index from global management consultancy Bain & Company. The firm states that products like vegan cheese and cultivated meat have not found a taste, texture, and price attractive enough to drive mainstream adoption at scale.
Jean-Charles van den Branden, Head of Bain’s Global Sustainability practice, said the realization of this weak consumer proposition caused the market caps of many high-profile companies to fall sharply after a strong hype phase. Venture capital investment in the wider category is also declining. Data from The Good Food Institute (GFI) shows global VC investment fell from €341 million to €306 million in the first half of 2026.
A Shift in Investor Focus
Despite the sector's overall struggles, investor interest is concentrating on fermentation technologies, particularly precision fermentation. GFI reports that precision fermentation companies raised €100 million in the first half of 2026, exceeding 2025 funding levels for the entire category during the same period. Biomass fermentation firms raised €99 million, up from €60 million last year.
Van den Branden noted this renewed investment could represent backers betting on technologies that might improve the consumer proposition. He cautioned, however, that it is not yet clear if new capital will lead to products consumers prefer at competitive prices. This illustrates a divergence where a category can disappoint overall while specific technologies still attract fresh funding.
Progress in Precision-Fermented Dairy
Precision-fermented dairy proteins, often called animal-free proteins, are being developed by several start-ups aiming to solve the texture and flavour problems of plant-based dairy. These companies are making regulatory and technical progress, though challenges with scale, affordability, and consumer acceptance persist. Many have shifted towards business-to-business ingredient solutions.
The Road Ahead
The next major hurdle for the precision fermentation sector, after securing regulatory clearance, will be scaling up production. Companies must also secure sufficient commercial demand to support a viable long-term business model. The sector's future hinges on translating technical advances into consumer-preferred products at competitive prices.





